Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu,1
Ellen Y. T. Chien,1
Clifford D. Mol,1
Gustavo Fenalti,1
Wei Liu,1
Vsevolod Katritch,2
Ruben Abagyan,2
Alexei Brooun,3
Peter Wells,3
F. Christopher Bi,3
Damon J. Hamel,2
Peter Kuhn,1
Tracy M. Handel,2
Vadim Cherezov,1
Raymond C. Stevens1,*
Abstract:
Chemokine receptors are critical regulators of cell migrationin the context of immune surveillance, inflammation, and development.The G protein–coupled chemokine receptor CXCR4 is specificallyimplicated in cancer metastasis and HIV-1 infection. Here wereport five independent crystal structures of CXCR4 bound toan antagonist small molecule IT1t and a cyclic peptide CVX15at 2.5 to 3.2 angstrom resolution. All structures reveal a consistenthomodimer with an interface including helices V and VI thatmay be involved in regulating signaling. The location and shapeof the ligand-binding sites differ from other G protein–coupledreceptors and are closer to the extracellular surface. Thesestructures provide new clues about the interactions betweenCXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoproteingp120.
1 Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. 2 Skaggs School of Pharmacy and Pharmaceutical Sciences, and San Diego Supercomputer Center, University of California, San Diego, La Jolla, CA 92093, USA. 3 Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, CA 92121, USA.
* To whom correspondence should be addressed. E-mail: stevens{at}scripps.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Valda Vinson (23 November 2010) Sci. Signal.3 (149), ec358.
[DOI: 10.1126/scisignal.3149ec358] |Abstract »
EDITORS' CHOICE
Valda Vinson (23 November 2010) Sci. Signal.3 (149), ec359.
[DOI: 10.1126/scisignal.3149ec359] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Structural Basis for Molecular Recognition at Serotonin Receptors.
C. Wang, Y. Jiang, J. Ma, H. Wu, D. Wacker, V. Katritch, G. W. Han, W. Liu, X.-P. Huang, E. Vardy, et al. (2013)
Science
340, 610-614
|Abstract »|Full Text »|PDF »
Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7.
A. Steen, S. Thiele, D. Guo, L. S. Hansen, T. M. Frimurer, and M. M. Rosenkilde (2013)
J. Biol. Chem.
288, 12511-12521
|Abstract »|Full Text »|PDF »
Chemokine CXCL1 Dimer Is a Potent Agonist for the CXCR2 Receptor.
A. Ravindran, K. V. Sawant, J. Sarmiento, J. Navarro, and K. Rajarathnam (2013)
J. Biol. Chem.
288, 12244-12252
|Abstract »|Full Text »|PDF »
Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits {beta}-Arrestin-mediated Endosomal Signaling.
Structure of the Human Angiotensin II Type 1 (AT1) Receptor Bound to Angiotensin II from Multiple Chemoselective Photoprobe Contacts Reveals a Unique Peptide Binding Mode.
D. Fillion, J. Cabana, G. Guillemette, R. Leduc, P. Lavigne, and E. Escher (2013)
J. Biol. Chem.
288, 8187-8197
|Abstract »|Full Text »|PDF »
Critical Hydrogen Bond Formation for Activation of the Angiotensin II Type 1 Receptor.
J. Cabana, B. Holleran, M.-E. Beaulieu, R. Leduc, E. Escher, G. Guillemette, and P. Lavigne (2013)
J. Biol. Chem.
288, 2593-2604
|Abstract »|Full Text »|PDF »
Conopeptide {rho}-TIA Defines a New Allosteric Site on the Extracellular Surface of the {alpha}1B-Adrenoceptor.
L. Ragnarsson, C.-I. A. Wang, A. Andersson, D. Fajarningsih, T. Monks, A. Brust, K. J. Rosengren, and R. J. Lewis (2013)
J. Biol. Chem.
288, 1814-1827
|Abstract »|Full Text »|PDF »
CC Chemokine Receptors and Chronic Inflammation--Therapeutic Opportunities and Pharmacological Challenges.
G. E. White, A. J. Iqbal, and D. R. Greaves (2013)
Pharmacol. Rev.
65, 47-89
|Abstract »|Full Text »|PDF »
Functional fusions of T4 lysozyme in the third intracellular loop of a G protein-coupled receptor identified by a random screening approach in yeast.
E. Mathew, F.-X. Ding, F. Naider, and M. E. Dumont (2013)
Protein Eng. Des. Sel.
26, 59-71
|Abstract »|Full Text »|PDF »
Novel Screening Assay for the Selective Detection of G-Protein-Coupled Receptor Heteromer Signaling.
R. M. van Rijn, J. H. Harvey, D. I. Brissett, J. N. DeFriel, and J. L. Whistler (2013)
J. Pharmacol. Exp. Ther.
344, 179-188
|Abstract »|Full Text »|PDF »
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012.
Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A{middle dot}mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function.
J. L. Moreno, C. Muguruza, A. Umali, S. Mortillo, T. Holloway, F. Pilar-Cuellar, G. Mocci, J. Seto, L. F. Callado, R. L. Neve, et al. (2012)
J. Biol. Chem.
287, 44301-44319
|Abstract »|Full Text »|PDF »
Reengineering the Collision Coupling and Diffusion Mode of the A2A-adenosine Receptor: PALMITOYLATION IN HELIX 8 RELIEVES CONFINEMENT.
S. Keuerleber, P. Thurner, C. W. Gruber, J. Zezula, and M. Freissmuth (2012)
J. Biol. Chem.
287, 42104-42118
|Abstract »|Full Text »|PDF »
Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.
A. Kirkpatrick, J. Heo, R. Abrol, and W. A. Goddard III (2012)
PNAS
109, 19988-19993
|Abstract »|Full Text »|PDF »
Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping.
M. Dong, X. Xu, A. M. Ball, J. A. Makhoul, P. C.- H. Lam, D. I. Pinon, A. Orry, P. M. Sexton, R. Abagyan, and L. J. Miller (2012)
FASEB J
26, 5092-5105
|Abstract »|Full Text »|PDF »
EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
R. Barroso, L. M. Munoz, S. Barrondo, B. Vega, B. L. Holgado, P. Lucas, A. Baillo, J. Salles, J. M. Rodriguez-Frade, and M. Mellado (2012)
FASEB J
26, 4841-4854
|Abstract »|Full Text »|PDF »
Identification of Structural Motifs Critical for Epstein-Barr Virus-Induced Molecule 2 Function and Homology Modeling of the Ligand Docking Site.
L. Zhang, A. Y. Shih, X. V. Yang, C. Kuei, J. Wu, X. Deng, N. S. Mani, T. Mirzadegan, S. Sun, T. W. Lovenberg, et al. (2012)
Mol. Pharmacol.
82, 1094-1103
|Abstract »|Full Text »|PDF »
Pharmacological Characterization and Modeling of the Binding Sites of Novel 1,3-Bis(pyridinylethynyl)benzenes as Metabotropic Glutamate Receptor 5-Selective Negative Allosteric Modulators.
C. Molck, K. Harpsoe, D. E. Gloriam, R. P. Clausen, U. Madsen, L. O. Pedersen, H. N. Jimenez, S. M. Nielsen, J. M. Mathiesen, and H. Brauner-Osborne (2012)
Mol. Pharmacol.
82, 929-937
|Abstract »|Full Text »|PDF »
Molecular Characterization of Oxysterol Binding to the Epstein-Barr Virus-induced Gene 2 (GPR183).
T. Benned-Jensen, C. Norn, S. Laurent, C. M. Madsen, H. M. Larsen, K. N. Arfelt, R. M. Wolf, T. Frimurer, A. W. Sailer, and M. M. Rosenkilde (2012)
J. Biol. Chem.
287, 35470-35483
|Abstract »|Full Text »|PDF »
The Thyrotropin Receptor Hinge Region as a Surrogate Ligand: Identification of Loci Contributing to the Coupling of Thyrotropin Binding and Receptor Activation.
C.-R. Chen, L. M. Salazar, S. M. McLachlan, and B. Rapoport (2012)
Endocrinology
153, 5058-5067
|Abstract »|Full Text »|PDF »
Modulation of Constitutive Activity and Signaling Bias of the Ghrelin Receptor by Conformational Constraint in the Second Extracellular Loop.
J. Mokrosinski, T. M. Frimurer, B. Sivertsen, T. W. Schwartz, and B. Holst (2012)
J. Biol. Chem.
287, 33488-33502
|Abstract »|Full Text »|PDF »
New Insights for Drug Design from the X-Ray Crystallographic Structures of G-Protein-Coupled Receptors.
Rapid Uptake and Degradation of CXCL12 Depend on CXCR7 Carboxyl-terminal Serine/Threonine Residues.
F. Hoffmann, W. Muller, D. Schutz, M. E. Penfold, Y. H. Wong, S. Schulz, and R. Stumm (2012)
J. Biol. Chem.
287, 28362-28377
|Abstract »|Full Text »|PDF »
Naturally evolved G protein-coupled receptors adopt metastable conformations.
K.-Y. M. Chen, F. Zhou, B. G. Fryszczyn, and P. Barth (2012)
PNAS
109, 13284-13289
|Abstract »|Full Text »|PDF »
Automatic modeling of mammalian olfactory receptors and docking of odorants.
G. Launay, S. Teletchea, F. Wade, E. Pajot-Augy, J.-F. Gibrat, and G. Sanz (2012)
Protein Eng. Des. Sel.
25, 377-386
|Abstract »|Full Text »|PDF »
HIV: Cell Binding and Entry.
C. B. Wilen, J. C. Tilton, and R. W. Doms (2012)
Cold Spring Harb Perspect Med
2, a006866
|Abstract »|Full Text »|PDF »
Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations.
K. M. Schlinkmann, A. Honegger, E. Tureci, K. E. Robison, D. Lipovsek, and A. Pluckthun (2012)
PNAS
109, 9810-9815
|Abstract »|Full Text »|PDF »
Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor.
E. E. Cawston, P. C. H. Lam, K. G. Harikumar, M. Dong, A. M. Ball, M. L. Augustine, E. Akgun, P. S. Portoghese, A. Orry, R. Abagyan, et al. (2012)
J. Biol. Chem.
287, 18618-18635
|Abstract »|Full Text »|PDF »
Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity.
K. Tadagaki, D. Tudor, F. Gbahou, P. Tschische, M. Waldhoer, M. Bomsel, R. Jockers, and M. Kamal (2012)
Blood
119, 4908-4918
|Abstract »|Full Text »|PDF »
Structure of the First Sphingosine 1-Phosphate Receptor.
CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant.
Y. Kang, Z. Wu, T. C. K. Lau, X. Lu, L. Liu, A. K. L. Cheung, Z. Tan, J. Ng, J. Liang, H. Wang, et al. (2012)
J. Biol. Chem.
287, 16499-16509
|Abstract »|Full Text »|PDF »
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
E. Ceraudo, R. Hierso, Y.-V. Tan, S. Murail, C. Rouyer-Fessard, P. Nicole, J.-C. Robert, N. Jamin, J.-M. Neumann, P. Robberecht, et al. (2012)
FASEB J
26, 2060-2071
|Abstract »|Full Text »|PDF »
Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1.
C. Dogo-Isonagie, S. Lam, E. Gustchina, P. Acharya, Y. Yang, S. Shahzad-ul-Hussan, G. M. Clore, P. D. Kwong, and C. A. Bewley (2012)
J. Biol. Chem.
287, 15076-15086
|Abstract »|Full Text »|PDF »
Differential determinants for coupling of distinct G proteins with the class B secretin receptor.
G. L. Garcia, M. Dong, and L. J. Miller (2012)
Am J Physiol Cell Physiol
302, C1202-C1212
|Abstract »|Full Text »|PDF »
Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development.
K. O'Callaghan, A. Kuliopulos, and L. Covic (2012)
J. Biol. Chem.
287, 12787-12796
|Abstract »|Full Text »|PDF »
HIV-1 Antiretroviral Drug Therapy.
E. J. Arts and D. J. Hazuda (2012)
Cold Spring Harb Perspect Med
2, a007161
|Abstract »|Full Text »|PDF »
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4.
M. Schiraldi, A. Raucci, L. M. Munoz, E. Livoti, B. Celona, E. Venereau, T. Apuzzo, F. De Marchis, M. Pedotti, A. Bachi, et al. (2012)
J. Exp. Med.
209, 551-563
|Abstract »|Full Text »|PDF »
Crystal Structure of a Lipid G Protein-Coupled Receptor.
M. A. Hanson, C. B. Roth, E. Jo, M. T. Griffith, F. L. Scott, G. Reinhart, H. Desale, B. Clemons, S. M. Cahalan, S. C. Schuerer, et al. (2012)
Science
335, 851-855
|Abstract »|Full Text »|PDF »
Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation.
C. Koole, D. Wootten, J. Simms, L. J. Miller, A. Christopoulos, and P. M. Sexton (2012)
J. Biol. Chem.
287, 3642-3658
|Abstract »|Full Text »|PDF »
The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation.
C. E. Carroll, S. Marada, D. P. Stewart, J. X. Ouyang, and S. K. Ogden (2012)
Development
139, 612-621
|Abstract »|Full Text »|PDF »
Structural aspects of M3 muscarinic acetylcholine receptor dimer formation and activation.
J. Hu, D. Thor, Y. Zhou, T. Liu, Y. Wang, S. M. McMillin, R. Mistry, R. A. J. Challiss, S. Costanzi, and J. Wess (2012)
FASEB J
26, 604-616
|Abstract »|Full Text »|PDF »
Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and invasion of human first-trimester decidual stromal cells.
L. Ren, Y.-Q. Liu, W.-H. Zhou, and Y.-Z. Zhang (2012)
Hum. Reprod.
27, 366-374
|Abstract »|Full Text »|PDF »
Modelling dynamics in protein crystal structures by ensemble refinement.
B. T. Burnley, P. V. Afonine, P. D. Adams, and P. Gros (2012)
eLife Sci
1, e00311
|Abstract »|Full Text »|PDF »
Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.
R. M. Potter, K. G. Harikumar, S. V. Wu, and L. J. Miller (2012)
J. Lipid Res.
53, 137-148
|Abstract »|Full Text »|PDF »
Structural Determinants of Ubiquitin-CXC Chemokine Receptor 4 Interaction.
V. Saini, A. Marchese, W.-J. Tang, and M. Majetschak (2011)
J. Biol. Chem.
286, 44145-44152
|Abstract »|Full Text »|PDF »
Helix 8 Plays a Crucial Role in Bradykinin B2 Receptor Trafficking and Signaling.
J. Feierler, M. Wirth, B. Welte, S. Schussler, M. Jochum, and A. Faussner (2011)
J. Biol. Chem.
286, 43282-43293
|Abstract »|Full Text »|PDF »
The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery.
J. A. Salon, D. T. Lodowski, and K. Palczewski (2011)
Pharmacol. Rev.
63, 901-937
|Abstract »|Full Text »|PDF »
Identification of a Novel Allosteric Binding Site in the CXCR2 Chemokine Receptor.
P. de Kruijf, H. D. Lim, L. Roumen, V. A. Renjaan, J. Zhao, M. L. Webb, D. S. Auld, J. C. H. M. Wijkmans, G. J. R. Zaman, M. J. Smit, et al. (2011)
Mol. Pharmacol.
80, 1108-1118
|Abstract »|Full Text »|PDF »
Allosteric and Orthosteric Sites in CC Chemokine Receptor (CCR5), a Chimeric Receptor Approach.
S. Thiele, A. Steen, P. C. Jensen, J. Mokrosinski, T. M. Frimurer, and M. M. Rosenkilde (2011)
J. Biol. Chem.
286, 37543-37554
|Abstract »|Full Text »|PDF »
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
L. J. Drury, J. J. Ziarek, S. Gravel, C. T. Veldkamp, T. Takekoshi, S. T. Hwang, N. Heveker, B. F. Volkman, and M. B. Dwinell (2011)
PNAS
108, 17655-17660
|Abstract »|Full Text »|PDF »
Role of the Transmembrane Domain 4/Extracellular Loop 2 Junction of the Human Gonadotropin-releasing Hormone Receptor in Ligand Binding and Receptor Conformational Selection.
Engineering a Prokaryotic Cys-loop Receptor with a Third Functional Domain.
R. Goyal, A. A. Salahudeen, and M. Jansen (2011)
J. Biol. Chem.
286, 34635-34642
|Abstract »|Full Text »|PDF »
The CXC Chemokine Receptor 4 Ligands Ubiquitin and Stromal Cell-derived Factor-1{alpha} Function through Distinct Receptor Interactions.
V. Saini, D. M. Staren, J. J. Ziarek, Z. N. Nashaat, E. M. Campbell, B. F. Volkman, A. Marchese, and M. Majetschak (2011)
J. Biol. Chem.
286, 33466-33477
|Abstract »|Full Text »|PDF »
Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5).
J. Garcia-Perez, P. Rueda, J. Alcami, D. Rognan, F. Arenzana-Seisdedos, B. Lagane, and E. Kellenberger (2011)
J. Biol. Chem.
286, 33409-33421
|Abstract »|Full Text »|PDF »
Structural Model of Ligand-G Protein-coupled Receptor (GPCR) Complex Based on Experimental Double Mutant Cycle Data: MT7 SNAKE TOXIN BOUND TO DIMERIC hM1 MUSCARINIC RECEPTOR.
C. Marquer, C. Fruchart-Gaillard, G. Letellier, E. Marcon, G. Mourier, S. Zinn-Justin, A. Menez, D. Servent, and B. Gilquin (2011)
J. Biol. Chem.
286, 31661-31675
|Abstract »|Full Text »|PDF »
Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore.
M. Dong, P. C.- H. Lam, D. I. Pinon, K. Hosohata, A. Orry, P. M. Sexton, R. Abagyan, and L. J. Miller (2011)
J. Biol. Chem.
286, 23888-23899
|Abstract »|Full Text »|PDF »
Comparative Fluorescence Resonance Energy Transfer Analysis of Metabotropic Glutamate Receptors: IMPLICATIONS ABOUT THE DIMERIC ARRANGEMENT AND REARRANGEMENT UPON LIGAND BINDINGS.
M. Yanagawa, T. Yamashita, and Y. Shichida (2011)
J. Biol. Chem.
286, 22971-22981
|Abstract »|Full Text »|PDF »
Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists.
S. P. Kawatkar, M. Yan, H. Gevariya, M. Y. Lim, S. Eisold, X. Zhu, Z. Huang, and J. An (2011)
Exp Biol Med
236, 844-850
|Abstract »|Full Text »|PDF »
Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.
Two distinct conformations of helix 6 observed in antagonist-bound structures of a {beta}1-adrenergic receptor.
R. Moukhametzianov, T. Warne, P. C. Edwards, M. J. Serrano-Vega, A. G. W. Leslie, C. G. Tate, and G. F. X. Schertler (2011)
PNAS
108, 8228-8232
|Abstract »|Full Text »|PDF »
New G-protein-coupled receptor structures provide insights into the recognition of CXCL12 and HIV-1 gp120 by CXCR4.
C. Zhong and J. Ding (2011)
Acta Biochim Biophys Sin
43, 337-338
|Full Text »|PDF »
Structure of an Agonist-Bound Human A2A Adenosine Receptor.
F. Xu, H. Wu, V. Katritch, G. W. Han, K. A. Jacobson, Z.-G. Gao, V. Cherezov, and R. C. Stevens (2011)
Science
332, 322-327
|Abstract »|Full Text »|PDF »
Helix 8 of the M1 Muscarinic Acetylcholine Receptor: Scanning Mutagenesis Delineates a G Protein Recognition Site.
R. G. Kaye, J. W. Saldanha, Z.-L. Lu, and E. C. Hulme (2011)
Mol. Pharmacol.
79, 701-709
|Abstract »|Full Text »|PDF »
G Protein Activation by Serotonin Type 4 Receptor Dimers: EVIDENCE THAT TURNING ON TWO PROTOMERS IS MORE EFFICIENT.
L. P. Pellissier, G. Barthet, F. Gaven, E. Cassier, E. Trinquet, J.-P. Pin, P. Marin, A. Dumuis, J. Bockaert, J.-L. Baneres, et al. (2011)
J. Biol. Chem.
286, 9985-9997
|Abstract »|Full Text »|PDF »
Recognition in the Face of Diversity: Interactions of Heterotrimeric G proteins and G Protein-coupled Receptor (GPCR) Kinases with Activated GPCRs.